Early reduction of CBF has been reported in mouse models of AD, such as mice overexpressing mutant forms of APP (Niwa et al., 2002; Ongali et al., 2010; Lacoste et al., 2013) and in mice expressing the ApoE4 gene allele (Lin et al., 2017). The gene discussed is APOE; the disease is Alzheimer disease.